[Clinical incidence of heterogenous resistance of Staphylococcus to penicillin and cephalosporin].
D002511:Cephalosporins / Q000494:pharmacology* / Q000627:therapeutic use; D003428:Cross Infection; D005260:Female; D006801:Humans; D008712:Methicillin / Q000627:therapeutic use; D010068:Oxacillin / Q000627:therapeutic use; D010403:Penicillin Resistance; D018805:Sepsis / Q000382:microbiology; D013203:Staphylococcal Infections / Q000188:drug therapy* / Q000453:epidemiology; D013210:Staphylococcus / Q000187:drug effects* / Q000302:isolation & purification
D002511:Cephalosporins; D008712:Methicillin; D010068:Oxacillin
Traduction clinique de la résistance hétérogène des staphylocoques aux pénicillines et céphalosporines.